Renal injury in cardiorenal syndrome type 1 is mediated by albumin
Related Experiment Video
Updated: Oct 3, 2025

A Large Animal Model for Acute Kidney Injury by Temporary Bilateral Renal Artery Occlusion
Published on: February 2, 2021
Yoshio Funahashi1, Mizuko Ikeda1, Rumie Wakasaki1
1Anesthesiology & Perioperative Medicine, Oregon Health & Science University, Portland, Oregon, USA.
Insights
Cardiorenal syndrome type 1 (CRS-1) causes acute kidney injury (AKI) and albuminuria. Albumin injures kidney tubular cells, worsening AKI, suggesting caution with albumin treatments in CRS-1 patients.
Area of Science:
- Nephrology
- Cardiology
- Physiology
Background:
- Cardiorenal syndrome type 1 (CRS-1) is a severe complication of acute cardiovascular disease, leading to acute kidney injury (AKI) and albuminuria.
- Albuminuria is linked to kidney disease progression and tubular injury, but its role in CRS-1 is unclear.
Purpose of the Study:
- To investigate albumin's role in CRS-1 pathophysiology.
- To determine if CRS-1 alters renal albumin handling and its impact on AKI.
Main Methods:
- Utilized in vivo (cardiac arrest/cardiopulmonary resuscitation model) and in vitro (HK2 cells) CRS-1 models.
- Assessed albuminuria, tubular injury, albumin filtration, and tubular uptake using microscopy and cell-based assays.
Main Results:
- Cardiac arrest/cardiopulmonary resuscitation induced significant albuminuria and tubular cell death.
- Exogenous albumin administration exacerbated AKI in CRS-1 models.
- Albumin uptake by proximal tubules became saturated, and albumin directly injured kidney tubular cells in vitro.
Conclusions:
- CRS-1 disrupts normal renal albumin handling, increasing tubular albumin exposure and causing injury, thereby worsening AKI.
- Findings suggest albumin may be detrimental in CRS-1 and warrant careful consideration during resuscitation therapies.
Abstract:
Cardiorenal syndrome type 1 (CRS-1) acute kidney injury (AKI) is a critical complication of acute cardiovascular disease but is poorly understood. AKI induces acute albuminuria. As chronic albuminuria is associated with worsening kidney disease and albumin has been implicated in tubular epithelial injury, we investigated whether albumin participates in CRS-1, and whether CRS-1 alters renal albumin handling. We report the role of albumin in in vivo and in vitro CRS-1 models. An established translational model, cardiac arrest and cardiopulmonary resuscitation (CA/CPR) induced severe acute albuminuria which correlated with tubular epithelial cell death. In vivo microscopy demonstrated CA/CPR-induced glomerular filtration of exogenous albumin, while administration of exogenous albumin after CA/CPR worsened AKI compared to iso-oncotic control. Increased albumin signal was observed in the proximal tubules of CA/CPR mice compared to sham. Comparison of albumin flux from tubular lumen to epithelial cells revealed saturated albumin transport within minutes of albumin injection after CA/CPR. In vitro, HK2 cells (human kidney tubular epithelial cells), exposed to oxygen-glucose deprivation were injured by albumin in a dose dependent fashion. This interference was unchanged by the tubular endocytic receptor megalin. In conclusion, CRS-1 alters albumin filtration and tubular uptake, leading to increased tubular exposure to albumin, which is injurious to tubular epithelial cells, worsening AKI. Our findings shed light on the pathophysiology of renal albumin and may guide interventions such as albumin resuscitation to improve CRS-1 outcomes. This investigation may have important translational relevance for patients that receive exogenous albumin as part of their CRS-1 treatment regimen.
Related Concept Videos
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury I: Introduction
Acute Kidney Injury V: Interprofessional Care
Nephrotic Syndrome I : Introduction
Acute Kidney Injury VI: Nursing Management

